Determinants of the adoption of injury risk reduction programmes in athletics (track and field): an online survey of 7715 French athletes.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
May 2022
Historique:
accepted: 02 11 2021
pubmed: 19 11 2021
medline: 16 4 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

To identify individual characteristics associated with the adoption of injury risk reduction programmes (IRRP) and to investigate the variations in sociocognitive determinants (ie, attitudes, subjective norms, perceived behavioural control and intentions) of IRRP adoption in athletics (track and field) athletes. We conducted a cross-sectional study using an online survey sent to athletes licensed with the French Federation of Athletics to investigate their habits and sociocognitive determinants of IRRP adoption. Sociodemographic characteristics, sports practice and history of previous injuries were also recorded. Logistic regression analyses and group comparisons were performed. The final sample was composed of 7715 athletes. From the multivariable analysis, competing at the highest level was positively associated with IRRP adoption (adjusted OR (AOR)=1.66; 99.9% CI 1.39 to 1.99 and AOR=1.48; 99.9% CI 1.22 to 1.80) and presenting a low number of past injuries was negatively associated with IRRP adoption (AOR=0.48; 99.9% CI 0.35 to 0.65 and AOR=0.61; 99.9% CI 0.44 to 0.84), both during their lifetime and the current season, respectively. These results were supported by higher scores of sociocognitive determinants among athletes who reported IRRP adoption compared with other athletes. Some characteristics of athletes seem to be associated with IRRP adoption either positively (competing at the highest level) or negatively (presenting a lower number of past injuries), whereas all the sociocognitive determinants tested appear to be linked to IRRP adoption. Since many athlete characteristics are difficult or impossible to change, IRRP promotion may be enhanced by targeting athletes' beliefs and intentions to adopt an IRRP.

Identifiants

pubmed: 34789458
pii: bjsports-2021-104593
doi: 10.1136/bjsports-2021-104593
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

499-505

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Alexis Ruffault (A)

Laboratory Sport, Expertise, and Performance (EA 7370), Institut National du Sport, de l'Expertise et de la Performance (French Institute of Sport (INSEP)), Paris, France.
Unité de Recherche Interfacultaire Santé et Société (URiSS), University of Liège, Liège, Belgium.

Marine Sorg (M)

Sports Medicine Unit, Department of Clinical and Exercise Physiology, University Hospital of Saint-Étienne, Saint-Étienne Cedex 2, France.

Simon Martin (S)

Center of Research on Welfare Health and Sport, Halmstad University (Högskolan i Halmstad), Halmstad, Sweden.
Laboratoire Adaptations Physiologiques à l'Exercice et Réadaptation à l'Effort (APERE), Université de Picardie Jules Verne, Amiens, France.

Christine Hanon (C)

Laboratory Sport, Expertise, and Performance (EA 7370), Institut National du Sport, de l'Expertise et de la Performance (French Institute of Sport (INSEP)), Paris, France.
French Athletics Federation (FFA), Paris, France.

Lison Jacquet (L)

Sports Medicine Unit, Department of Clinical and Exercise Physiology, University Hospital of Saint-Étienne, Saint-Étienne Cedex 2, France.

Evert Verhagen (E)

Amsterdam Collaboration on Health & Safety in Sports, Department of Public and Occupational Health, Amsterdam Movement Sciences, Amsterdam UMC, University Medical Centers - Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Pascal Edouard (P)

Sports Medicine Unit, Department of Clinical and Exercise Physiology, University Hospital of Saint-Étienne, Saint-Étienne Cedex 2, France Pascal.Edouard42@gmail.com.
Inter-University Laboratory of Human Movement Sciences (LIBM EA 7424), University Jean Monnet Saint-Étienne, University of Lyon, Saint-Étienne, France.
European Athletics Medical & Anti Doping Commission, European Athletics Association (EAA), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH